Summary: New research shows that combining genetic susceptibility with cardiovascular and lifestyle risk markers produces a more precise prediction of who will develop dementia. While inherited factors such as APOE4 and family history strongly influence risk, the study highlights that modifiable conditions — including hypertension, obesity, diabetes, and other vascular risks — play an equally important role and offer actionable opportunities for prevention.
Across a six-year follow-up, people with multiple overlapping genetic and cardiovascular risk indicators were far more likely to progress from normal cognition or mild cognitive impairment (MCI) to dementia. These findings emphasize the value of early assessment and interventions that target vascular health and lifestyle, even among individuals with elevated genetic vulnerability.
Key Facts:
- Combined risks increase likelihood: Each additional genetic or cardiovascular indicator substantially raises the chance of developing dementia.
- Modifiable factors are powerful: Hypertension, diabetes, obesity, and unhealthy lifestyle behaviors can be addressed to reduce overall risk.
- Early action can change outcomes: Interventions begun before dementia symptoms appear may delay or prevent clinical progression.
Source: UCSF
Study overview
A UC San Francisco–led study evaluated how combining genetic risk measures with cardiovascular disease risk factors improves prediction of dementia. The analysis used data from approximately 3,500 adults enrolled in the National Alzheimer’s Coordinating Center (NACC) and the Alzheimer’s Disease Neuroimaging Initiative (ADNI).
Participants had an average age of 75 at baseline. None had dementia at enrollment, though roughly one in four had mild cognitive impairment (MCI), a condition that often precedes dementia. Over six years, about one in seven participants died. Among surviving participants who began the study with normal cognition or MCI, roughly one in four progressed to dementia during follow-up.
The investigators created an additive risk score that combined four types of indicators:
- Family history of dementia (parent or sibling)
- Presence of at least one copy of the APOE4 allele
- A high polygenic risk score capturing many smaller genetic effects
- A high cardiovascular risk score reflecting factors such as high LDL cholesterol, hypertension, obesity, and diabetes
The team also screened for rare mutations linked to early‑onset Alzheimer’s disease; none of the study participants carried these rare variants.
Risk rose with each additional indicator. The paper reports specific multipliers for combinations of risk factors (for example, one factor, two factors, three factors, or all four), and the abstract summarizes an additive relationship in which each extra high‑risk indicator was associated with a roughly one‑third increase in the hazard of developing dementia.
Clinical implications
The study reframes dementia risk as a mix of immutable and modifiable elements. Genetics account for a substantial portion of dementia susceptibility, but non‑genetic factors such as social isolation, untreated hearing loss, physical inactivity, and especially vascular health conditions make up a large and addressable share of risk.
“With Alzheimer’s disease, you may have several vascular diseases involved, like hypertension and diabetes,” said corresponding author Shea Andrews, PhD. “If you make lifestyle changes and improve control of illnesses like these, you could reduce the amount of overall damage to the brain, potentially delaying or even preventing symptoms.”
Andrews noted that newer diagnostic tools and emerging treatments make it useful to identify elevated risk earlier. Early-stage disease can now be detected with blood biomarker tests or specialized brain imaging such as PET scans, and some therapies may slow progression when started early.
The study authors anticipate that genetic information about dementia risk will become more accessible in clinical settings over the coming years. An envisioned model is that patients who are concerned about family history could discuss genetic data with their primary care provider to create a tailored plan for lowering modifiable risks.
“I think focusing on what patients can control gives them agency and ownership,” said Kristine Yaffe, MD, the study’s senior author and a leading researcher on modifiable dementia risk factors. “This approach allows people to take proactive steps rather than wait for symptoms to appear.”
Funding and disclosures
The work was supported by the National Alzheimer’s Coordinating Center New Investigator Award (5U24AG072122) and grants from the National Institutes of Health (R35AG071916 and U19AG069701). For additional funding details and disclosures, see the published study.
Key Questions Answered:
A: They produce an additive profile: multiple high‑risk indicators together sharply increase the probability of developing dementia compared with any single risk factor alone.
A: Family history, APOE4 carrier status, a high Alzheimer’s polygenic risk score, and elevated cardiovascular risk were all significant contributors in this cohort.
A: Yes. Improving vascular health and addressing modifiable behaviors—such as managing blood pressure, blood sugar, cholesterol, weight, physical activity, and hearing—may delay or prevent the onset of dementia symptoms.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full by the editorial team.
- Additional context was added by staff to clarify clinical and research implications.
About this Alzheimer’s disease, genetics, and CVD research news
Author: Suzanne Leigh
Source: UCSF
Contact: Suzanne Leigh – UCSF
Image: The image is credited to Neuroscience News
Original Research: Open access. “The role of genomic-informed risk assessments in predicting dementia outcomes” by Paulina Tolosa-Tort et al., Alzheimer’s & Dementia. DOI: 10.1002/alz.70826
Abstract
The role of genomic-informed risk assessments in predicting dementia outcomes
INTRODUCTION
Integrating genetic and clinical risk factors into genomic‑informed dementia risk reports can provide patients and clinicians with a clearer view of individual vulnerability, helping to guide personalized strategies to protect brain health.
METHODS
The investigators built an additive score combining a modified cardiovascular risk index (mCAIDE), family history of dementia, APOE genotype, and an Alzheimer’s disease polygenic risk score using data from NACC and ADNI, and evaluated how this composite score related to progression to all‑cause dementia.
RESULTS
A total of 81% of participants had at least one high‑risk indicator for dementia. The study found a dose‑response relationship: each additional risk indicator was associated with an increased hazard of dementia onset.
DISCUSSION
Most patients seen in memory and aging clinics carried at least one high‑risk indicator. The observed dose‑response pattern supports the value of combined genetic and vascular risk assessment to identify individuals who could benefit from targeted prevention efforts aimed at modifiable factors.